These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34286440)

  • 21. Common variants of chemokine receptor gene CXCR3 and its ligands CXCL10 and CXCL11 associated with vascular permeability of dengue infection in peninsular Malaysia.
    Hoh BP; Umi-Shakina H; Zuraihan Z; Zaiharina MZ; Rafidah-Hanim S; Mahiran M; Khairudin NY; Benedict LH; Masliza Z; Christopher KC; Sazaly AB
    Hum Immunol; 2015 Jun; 76(6):421-6. PubMed ID: 25858769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding.
    Cox JH; Dean RA; Roberts CR; Overall CM
    J Biol Chem; 2008 Jul; 283(28):19389-99. PubMed ID: 18411283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration, adhesion and internalization in response to CXCL11.
    Dagan-Berger M; Feniger-Barish R; Avniel S; Wald H; Galun E; Grabovsky V; Alon R; Nagler A; Ben-Baruch A; Peled A
    Blood; 2006 May; 107(10):3821-31. PubMed ID: 16368892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The intratumoral CXCR3 chemokine system is predictive of chemotherapy response in human bladder cancer.
    Vollmer T; Schlickeiser S; Amini L; Schulenberg S; Wendering DJ; Banday V; Jurisch A; Noster R; Kunkel D; Brindle NR; Savidis I; Akyüz L; Hecht J; Stervbo U; Roch T; Babel N; Reinke P; Winqvist O; Sherif A; Volk HD; Schmueck-Henneresse M
    Sci Transl Med; 2021 Jan; 13(576):. PubMed ID: 33441425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck Cancers.
    Kumaravel S; Singh S; Roy S; Venkatasamy L; White TK; Sinha S; Glaser SS; Safe SH; Chakraborty S
    Am J Pathol; 2020 Apr; 190(4):900-915. PubMed ID: 32035061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection.
    Meyer M; Hensbergen PJ; van der Raaij-Helmer EM; Brandacher G; Margreiter R; Heufler C; Koch F; Narumi S; Werner ER; Colvin R; Luster AD; Tensen CP; Werner-Felmayer G
    Eur J Immunol; 2001 Aug; 31(8):2521-7. PubMed ID: 11500837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Airway smooth muscle CXCR3 ligand production: regulation by JAK-STAT1 and intracellular Ca²⁺.
    Tan X; Alrashdan YA; Alkhouri H; Oliver BG; Armour CL; Hughes JM
    Am J Physiol Lung Cell Mol Physiol; 2013 Jun; 304(11):L790-802. PubMed ID: 23564506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CXCR3-CXCL11 signaling axis mediates macrophage recruitment and dissemination of mycobacterial infection.
    Torraca V; Cui C; Boland R; Bebelman JP; van der Sar AM; Smit MJ; Siderius M; Spaink HP; Meijer AH
    Dis Model Mech; 2015 Mar; 8(3):253-69. PubMed ID: 25573892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of antigen-specific CD8 T cell responses by co-delivery of Fc-fused CXCL11.
    Namkoong H; Song MY; Seo YB; Choi DH; Kim SW; Im SJ; Sung YC; Park Y
    Vaccine; 2014 Feb; 32(10):1205-12. PubMed ID: 23928465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer.
    Benhadjeba S; Edjekouane L; Sauvé K; Carmona E; Tremblay A
    Mol Oncol; 2018 Oct; 12(10):1689-1705. PubMed ID: 30051594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function.
    Colvin RA; Campanella GS; Sun J; Luster AD
    J Biol Chem; 2004 Jul; 279(29):30219-27. PubMed ID: 15150261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated immuno-transcriptomic analysis of ovarian cancer identifies a four-chemokine-dominated subtype with antitumor immune-active phenotype and favorable prognosis.
    Zhuo L; Meng F; Sun K; Zhou M; Sun J
    Br J Cancer; 2024 Oct; 131(6):1068-1079. PubMed ID: 39095528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment.
    Reynders N; Abboud D; Baragli A; Noman MZ; Rogister B; Niclou SP; Heveker N; Janji B; Hanson J; Szpakowska M; Chevigné A
    Cells; 2019 Jun; 8(6):. PubMed ID: 31216755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrating individual functional moieties of CXCL10 and CXCL11 into a novel chimeric chemokine leads to synergistic antitumor effects: a strategy for chemokine-based multi-target-directed cancer therapy.
    Wang P; Yang X; Xu W; Li K; Chu Y; Xiong S
    Cancer Immunol Immunother; 2010 Nov; 59(11):1715-26. PubMed ID: 20706716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis.
    Zohar Y; Wildbaum G; Novak R; Salzman AL; Thelen M; Alon R; Barsheshet Y; Karp CL; Karin N
    J Clin Invest; 2014 May; 124(5):2009-22. PubMed ID: 24713654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation.
    Loos T; Mortier A; Gouwy M; Ronsse I; Put W; Lenaerts JP; Van Damme J; Proost P
    Blood; 2008 Oct; 112(7):2648-56. PubMed ID: 18645041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expressions of CXCL9, CXCL10 and CXCL11 in renal tubular epithelial cells induced by IFN-γ].
    Lin Q; Song Y; Zhu X; Yang S; Zheng J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):137-40. PubMed ID: 23388331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells.
    Fenwick PS; Macedo P; Kilty IC; Barnes PJ; Donnelly LE
    PLoS One; 2015; 10(6):e0128757. PubMed ID: 26090665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11).
    Sauty A; Colvin RA; Wagner L; Rochat S; Spertini F; Luster AD
    J Immunol; 2001 Dec; 167(12):7084-93. PubMed ID: 11739530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.
    Lasagni L; Francalanci M; Annunziato F; Lazzeri E; Giannini S; Cosmi L; Sagrinati C; Mazzinghi B; Orlando C; Maggi E; Marra F; Romagnani S; Serio M; Romagnani P
    J Exp Med; 2003 Jun; 197(11):1537-49. PubMed ID: 12782716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.